Search Count: 1,143
 |
Crystal Structure Of Sting Ctd Complex With Small Molecular Inhibitor Ddo-88101
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2026-06-17 Classification: IMMUNE SYSTEM Ligands: A1ETJ, CA |
 |
Crystal Structure Of Sting Ctd Complex With Small Molecular Inhibitor Ddo-88109
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2026-06-17 Classification: IMMUNE SYSTEM Ligands: CA, A1ETP |
 |
Structure Of Human Proteasome Atpase-Cp Intermediate Assembles With 15Min Rapaprotin Addition
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:3.80 Å Release Date: 2026-06-17 Classification: HYDROLASE Ligands: ATP, ADP |
 |
Structure Of Human Proteasome Atpase-Cp Intermediate Assembles With 90Min Rapaprotin Addition
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:3.10 Å Release Date: 2026-06-17 Classification: HYDROLASE Ligands: ATP, ADP |
 |
Structure Of Human Proteasome Atpase-Cp Intermediate Assembles With 90Min Rapaprotin Addition
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:4.10 Å Release Date: 2026-06-17 Classification: HYDROLASE Ligands: ATP, ADP |
 |
Cryo-Em Structure Of The Human Beta2-Adrenergic Receptor In Complex With A Novel Antagonist
Organism: Homo sapiens, Enterobacteria phage t4, Lama glama
Method: ELECTRON MICROSCOPY Resolution:3.04 Å Release Date: 2026-06-10 Classification: MEMBRANE PROTEIN Ligands: BER |
 |
Crystal Structure Of Sars-Cov-2 Main Protease A173V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON |
 |
Crystal Structure Of Sars-Cov-2 Main Protease P168 Deletion Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON |
 |
Crystal Structure Of Sars-Cov-2 Main Protease E166V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease G143S Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: GOL, 7ON |
 |
Crystal Structure Of Sars-Cov-2 Main Protease H172Y Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease L50F/E166V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0 |
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I/M165I Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I/M165T Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease M165T Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease S144A Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease T21I/E166V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49T Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease Q192L Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |